AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

FEEDBACK PLC

AGM Information Oct 13, 2025

7636_agm-r_2025-10-13_c3973afc-afe4-463c-8bcc-dac35e98cd84.html

AGM Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 1620D

Feedback PLC

13 October 2025

Feedback plc

Result of Annual General Meeting

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical infrastructure specialist, announces that at the Annual General Meeting held today all resolutions were duly passed.

The results of the poll (including proxy votes on the resolutions) are included below.

Resolutions Votes for* % of votes cast** Votes against % of votes cast** Votes withheld***
1)   To receive the Annual Report and Accounts for the financial year ended 31 May 2025 17,771,063 99.999% 120 0.001% 86
2) To accept the Directors' Remuneration Report for the financial year ended 31 May 2025 17,763,723 99.96% 7,386 0.04% 160
3) To re-elect Adam Denning as a director of the Company 17,756,812 99.97% 6,120 0.03% 8,337
4) To re-elect Annemijn Eschauzier as a director of the Company 17,756,546 99.96% 6,386 0.04% 8,337
5) To re-elect Dr. Tom Oakley as a director of the Company 17,763,989 99.96% 7,120 0.04% 160
6) To re-elect Anesh Patel as a director of the Company 17,764,989 99.97% 6,120 0.03% 160
7) To re-elect Philipp Prince as a director of the Company 17,758,796 99.98% 4,136 0.02% 8,337
8) To re-elect Professor Rory Shaw as a director of the Company 17,719,573 99.71% 51,536 0.29% 160
9) To re-appoint Price Bailey LLP as auditor of the Company 17,770,989 99.999% 120 0.001% 160
10) To authorise the Directors to determine the fees payable to the auditor 17,770,989 99.999% 120 0.001% 160
11) To authorise the Directors to allot Equity Securities within the parameters set out in the Notice 17,720,805 99.72% 50,304 0.28% 160
Special Resolutions
12) Subject to the passing of resolution 11, to authorise the Directors to allot Equity Securities for cash as if Section 561 of the CA 2006 did not apply 17,706,894 99.68% 56,038 0.32% 8,337
13) Subject to the passing of resolution 11 and in addition to resolution 12, to authorise the Directors to allot Equity Securities for cash as if Section 561 of the CA 2006 did not apply 17,707,894 99.69% 55,038 0.31% 8,337

Notes:

* "Votes For" include votes giving the Chairman discretion.

** Percentages exclude "Votes Withheld".

*** "Votes Withheld" are not votes in law and do not count in the number of votes counted for or against a resolution.

As at 13 October, there were 43,814,779 ordinary shares in issue. Shareholders are entitled to one vote per share.

The full text of each resolution is available in the Notice of Annual General Meeting, published on the Company's website.

-Ends-

Enquiries:

Feedback plc

Tom Oakley, CEO

Anesh Patel, CFO
+44 (0) 20 3997 7634

[email protected]
Panmure Liberum Limited (NOMAD and Broker)

Emma Earl/ Mark Rogers (Corporate Finance)

Rupert Dearden (Corporate Broking)
+44 (0)20 7886 2500
Walbrook PR Ltd; Tel: 020 7933 8780 or [email protected]
Nick Rome/Joe Walker 07748 325 236 or 07407 020 470

About Feedback plc

Feedback plc liberates the data and knowledge from multiple healthcare IT systems and delivers better workflow to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. We connect care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

By linking different clinical systems together into a seamless view of the patient, we can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

Bleepa® is our communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance. CareLocker® is our patient-facing platform that gives patients access and control over their diagnostic and other clinical data.

The Company has a number of growth opportunities domestically and internationally across a range of public and private healthcare markets including the NHS. Our highly scalable software-as-a-service (SaaS) based model is expected to provide increasing levels of revenue visibility as the Company grows its customer base.

https://feedbackmedical.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGEXLFFEBLBFBF

Talk to a Data Expert

Have a question? We'll get back to you promptly.